Zynex (ZYXI) Registration Filing summary

Company overview and business model

• Designs, manufactures, and markets medical devices for pain management and rehabilitation, primarily through Zynex Medical, Inc. and Zynex Monitoring Solutions, Inc.

• Main products include NexWave (TENS/NMES/IFC device), private-labeled rehabilitation products, NeuroMove (for neuroplasticity), InWave (urinary incontinence), and M-Wave (muscle stimulation).

• Zynex Monitoring Solutions develops non-invasive patient monitoring devices, including fluid monitoring systems and investigational laser-based pulse oximeters.

• Products are marketed in the U.S., require a physician's prescription, and are covered by most insurance plans and Medicare.

• Recent acquisitions and ongoing R&D focus on expanding monitoring solutions and addressing unmet clinical needs.

Risk factors and disclosures

• Investment involves a high degree of risk, with risks detailed in the most recent Annual Report on Form 10-K and subsequent filings.

• Forward-looking statements are subject to risks and uncertainties, including business strategy, capital needs, and market conditions.

• No revenue generated from Zynex Monitoring Solutions for 2023 and 2024 as products are still in development.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for general corporate purposes, including working capital, unless otherwise specified in a prospectus supplement.